I can't believe I'm doing this, but gonna answer a valid question from instant coffee
Inovio wasn't willing to give up those vaccines that are closest because
A) Roche didn't make it to be the largest biotech company without being a value investor. They got the best value for the prostate cancer vaccine and the Hep B vaccine because they are still very early stage and can make boat loads of money (the market is extremely large on the most common internal cancer in men, and most people already get a Hep B vaccine).
B) Dr. Kim is pretty thrifty himself. Inovio wasn't going to give up the flu program, HIV program, or HPV program for 10 million dollars now and 400 million later on. Each one of those is worth a potential of a few billion dollars (with HIV being the riskiest but definitely if it works the most profitable).
C) Now that someone else made a statement that INO is the real deal (Roche) that makes them much more marketable to other biotechs. If INO gets an offer for partnership on a vaccine, there is a chance Roche may try to outbid them to get that technology too.
Bashers cant answer to technical answers, their morons dressed up in morons clothes!!! They have no idea about what they are talking about, thats why the same broken record over and over it's the extent of all their is with them.